Michela Francalanci
- Immunology top 2%
- Immunotherapy and Immune Responses 3
- Oncology top 5%
- Chemokine receptors and signaling 9
- Immunology and Allergy top 5%
- Genetics top 5%
- Transplantation top 5%
-
- Cystic Fibrosis Research Advances 15
- Neonatal Respiratory Health Research 8
- Tracheal and airway disorders 6
-
- Cancer, Hypoxia, and Metabolism 4
-
- Adrenal and Paraganglionic Tumors 4
-
- Adipose Tissue and Metabolism 3
Michela Francalanci
34 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Immunology 1.1k
- Oncology 979
- Immunology and Allergy 199
- Genetics 221
- Transplantation 46
Countries citing papers authored by Michela Francalanci
This map shows the geographic impact of Michela Francalanci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michela Francalanci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michela Francalanci more than expected).
Fields of papers citing papers by Michela Francalanci
This network shows the impact of papers produced by Michela Francalanci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michela Francalanci. The network helps show where Michela Francalanci may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michela Francalanci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 39 | |
| 4 | 2021 | 10 | |
| 5 | 2021 | 38 | |
| 6 | 2021 | 21 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 64 | |
| 9 | 2021 | 9 | |
| 10 | 2019 | 16 | |
| 11 | 2017 | 31 | |
| 12 | 2012 | 146 | |
| 13 | 2012 | 22 | |
| 14 | Effects and kinetics of mitotane in in vitro and in vivo models of adrenocortical carcinoma | 2011 | 1 |
| 15 | 2010 | 22 | |
| 16 | 2009 | 34 | |
| 17 | 2009 | 35 | |
| 18 | An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4breakdown → | 2003 | 581 |
| 19 | 2001 | 254 | |
| 20 | 2001 | 316 |
About Michela Francalanci
Michela Francalanci is a scholar working on Immunology and Allergy, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Genetics, having authored 36 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (15 papers), Chemokine receptors and signaling (9 papers), Neonatal Respiratory Health Research (8 papers), Tracheal and airway disorders (6 papers), Cancer, Hypoxia, and Metabolism (4 papers), Adrenal and Paraganglionic Tumors (4 papers), Adipose Tissue and Metabolism (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (979 citations), Immunology and Allergy (199 citations), Genetics (221 citations) and Transplantation (46 citations). Michela Francalanci has collaborated with scholars based in Italy, Switzerland and Germany. Frequent co-authors include Francesco Annunziato, Paola Romagnani, Mario Serio, Elena Lazzeri, Laura Lasagni, Enrico Maggi, Sergio Romagnani, Lorenzo Cosmi, Fabio Marra and Benedetta Mazzinghi. Their work appears in journals such as Journal of Cystic Fibrosis, Endocrine Related Cancer, Respiratory Medicine, European Journal of Cell Biology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.